Viridian Therapeutics, Inc.\DE (VRDN) Dividends Paid - Common (2013)

Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Dividends Paid - Common came in at $45000.0 in Q4 2013, down 25.0% quarter-over-quarter from $60000.0 in Q3 2013.

Viridian Therapeutics, Inc.\DE (VRDN) Dividends Paid - Common (2013) Analysis & Trends

Viridian Therapeutics, Inc.\DE's Dividends Paid - Common history runs 1 years deep, the most recent figure standing at $45000.0 for Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 97.80 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Viridian Therapeutics, Inc.\DE 229.55 Mn 229.55 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 45,000.00
Dec 31, 2013 45,000.00
Sep 30, 2013 60,000.00
Sep 30, 2013 60,000.00
Jun 30, 2013 90,000.00
Jun 30, 2013 90,000.00